Furthermore, Raji-tumor bearing mice treated with 20BBZ-Bcl-2 CAR T cells showed prolonged overall survival compared to that of the 20BBZ CAR-T cell treatment group (Figure 6D). This evidence concerns the gene BCL2 and neoplasm.